Gregory D. Gorgas
President, CEO, Secretary & DirectorMr. Gregory D. Gorgas, also known as Greg, M.B.A. has been the Chief Executive Officer, President, Secretary of Artelo Biosciences, Inc. since April 3, 2017 and served as its Treasurer until November 01, 2025 and served as its Principle Financial & Accounting Officer until November 01, 2025 and served as Chief Financial Officer. He has extensive experience in the biopharmaceutical industry and his past leadership positions at successful companies. Mr. Gorgas has experience in drug product commercialization, with an emphasis in launching new products, building commercial infrastructure and leading start-up operations. Mr. Gorgas served as Senior Vice President of Commercial and Corporate Officer at Mast Therapeutics, Inc. from July 25, 2011 to January 2017. He was a key contributor to the blockbuster success of Rituxan(R) while at Biogen Idec, where, he led global marketing for the oncology franchise. From November 2009 to July 2011, Mr. Gorgas served as Managing Director at Theragence, Inc., which he co-founded, that applies proprietary computational intelligence to analyze clinical data. He served as Senior Vice President of Commercial at Savara Inc. until December 28, 2016. From November 2008 to July 2011, Mr. Gorgas also served as an independent consultant, providing commercial and business development consulting services to pharmaceutical, biotechnology and medical device companies. From 1997 to October 2008, Mr. Gorgas held positions of increasing responsibility with Biogen Idec Inc. From March 2006 to October 2008, Mr. Gorgas served as Senior Director, global and U.S. marketing at Biogen Idec, where he was responsible for the strategic vision and operational commercialization of the company’s worldwide cancer business. In this role, he hired and led the team in marketing, operations, project management and business development in Europe and the US. Prior to such time, he held responsibilities in sales, commercial operations and project team and alliance management. Prior to Biogen Idec, he held sales and Manager positions with Chiron Corporation, Cetus and The Upjohn Company. He has been a Director of Artelo Biosciences, Inc. since April 03, 2017. He serves as a Director of Theragence. He serves as a Member of Advisory Board at Klotho Therapeutics. Mr. Gorgas holds an M.B.A. from the University of Phoenix and a B.A. in economics from California State University, Northridge.
Positions
- Company NameArtelo Biosciences, Inc.Stock CodeARTLPositionPresident, CEO, Secretary & DirectorColleagues
- CLConnie L. MatsuiIndependent Chairperson of the Board
- MEMark E. SpringCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- AYAndrew YatesSenior VP & Chief Scientific Officer
- SDSteven D. ReichChief Medical Officer
- JHJason H. BaybuttSenior Vice President of Finance
- SKSteven KellyIndependent Director
- DWDouglas W. BlayneyIndependent Director
- TATamara A. FavoritoIndependent Director
